The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4753-4760

  Tsubota, Kazuo ^a,b   Nishiyama, Tatsuaki ^b,c,d   Mishima, Kenji ^d   Inoue, Hiroko ^d   Doi, Takeshi ^c   Hattori, Yukio ^c   Kodama, Tatsuhiko ^e   Higuchi, Akihiro ^g   Hayashi, Yoshio ^f   Saito, Ichiro ^b,d  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KOWA COMPANY LTD   (Japan)

^d TSURUMI UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; FRACTALKINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EXOCRINE GLAND; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SALIVATION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; TRANSGENE; UPREGULATION; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL MOTION; CYTOLOGY; IMMUNOBLOTTING; LACRIMAL APPARATUS; LACRIMAL FLUID; METABOLISM; PHYSIOLOGY; SALIVARY GLAND; SECRETION; THYMECTOMY; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CX3CL1; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; TEARS; THYMECTOMY;

EID: 70349568520     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2596     Document Type: Article

References (34)

1. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986;29:577-585.
2. Chan EK, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest. 1991;87:68-76.
3. Kessler HS. A laboratory model for Sjogren's syndrome. Am J Pathol. 1968;52:671-685.
4. Hoffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE. Sjogren's syndrome in MRL/l and MRL/n mice. Arthritis Rheum. 1984;27:157-165.
5. Jonsson R, Tarkowski A, Backman K, Holmdahl R, Klareskog L. Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology. 1987;60:611-616.
6. Haneji N, Hamano H, Yanagi K, Hayashi Y. A new animal model for primary Sjogren's syndrome in NFS/sld mutant mice. J Immunol. 1994;153:2769-2777.
7. Hayashi Y, Haneji N, Hamano H, et al. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjogren's syndrome. Cell Immunol. 1996;171:217-225.
8. Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science. 1997;276:604-607.
9. Ishimaru N, Saegusa K, Yanagi K, et al. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis. Am J Pathol. 1999;155:173-181.
10. Inoue H, Tsubota K, Ono M, et al. Possible involvement of EBVmediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol. 2001;166:5801-5809.
11. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci. 2001;42:321-327.
12. Nagaraju K, Cox A, Casciola-Rosen L, Rosen A. Novel fragments of the Sjogren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum. 2001;44:2376-2386.
13. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392: 565-568.
14. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
15. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membranebound chemokine with a CX3C motif. Nature. 1997;385:640-644.
16. Feng L, Chen S, Garcia GE, et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int. 1999;56:612-620.
17. Muehlhoefer A, Saubermann LJ, Gu X, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol. 2000;164:3368-3376.
18. Teupser D, Pavlides S, Tan M, et al. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A. 2004;101:17795-17800.
19. Yu YR, Fong AM, Combadiere C, et al. Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer. 2007;121:316-322.
20. Hayashi Y, Kojima A, Hata M, Hirokawa K. A new mutation involving the sublingual gland in NFS/N mice: partially arrested mucous cell differentiation. Am J Pathol. 1988;132:187-191.
21. White S, Casarett G. Induction of experimental autoallergic sialadenitis. J Immunol. 1974;112:178-185.
22. Ishimaru N, Yoneda T, Saegusa K, et al. Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis. Am J Pathol. 2000;156:1557-1564.
23. Ting CN, Rosenberg MP, Snow CM, Samuelson LC, Meisler MH. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev. 1992;6: 1457-1465.
24. Wildenberg ME, van Helden-Meeuwsen CG, Drexhage HA, Versnel MA. Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland. Arthritis Res Ther. 2008;10:R69.
25. Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol. 1988;15:505-509.
26. Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren's syndrome. Curr Rheumatol Rep. 2003;5:311-316.
27. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med. 1998;188:1413-1419.
28. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO. Fractalkine expression in human renal inflammation. J Pathol. 2002;196:85-90.
29. Chen S, Bacon KB, Li L, et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med. 1998;188:193-198.
30. Habasque C, Satie AP, Aubry F, Jegou B, Samson M. Expression of fractalkine in the rat testis: molecular cloning of a novel alternative transcript of its gene that is differentially regulated by pro-inflammatory cytokines. Mol Hum Reprod. 2003;9:449-455.
31. Hunger RE, Carnaud C, Vogt I, Mueller C. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest. 1998;101:1300-1309.
32. Pepose JS, Akata RF, Pflugfelder SC, Voigt W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjogren's syndrome. Ophthalmology. 1990;97:1599-1605.
33. Adamson TC 3rd, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol. 1983;130:203-208.
34. Matsumoto I, Tsubota K, Satake Y, et al. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J Clin Invest. 1996;97:1969-1977.